FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Procainamide Hydrochloride Injection, USP
Status: Resolved
»Duration of Shortage: 09/27/2016 - 12/30/2020
»Therapeutic Categories: Cardiovascular; Renal

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Revised 12/30/2020)

Company Contact Information:
800-423-4136

Presentation
  • 100 mg/1 mL injection; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3399-5)
Note:
  • Available

Hospira, Inc. (Revised 12/30/2020)

Company Contact Information:
844-646-4398

Presentation
  • 1,000 mg/10 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1902-01)
  • 1,000 mg/2 mL (500 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1903-01)
Note:
  • N/A

Nexus Pharmaceuticals, Inc. (Revised 12/30/2020)

Company Contact Information:
888-806-4606

Presentation
  • 500 mg/mL, 2 mL (NDC 14789-900-02)
  • 100 mg/mL, 10 mL (NDC 14789-900-10)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English